Related Experiment Video

Updated: Sep 26, 2026

Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models
10:04

Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models

Published on: March 13, 2018

In vivo imaging of molecular-genetic targets for cancer therapy

Juri Gelovani Tjuvajev1, Ronald G Blasberg

  • 1Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

Cancer Cell
|May 3, 2003
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Fluorescence Molecular Tomography for In Vivo Imaging of Glioblastoma Xenografts
07:52

Fluorescence Molecular Tomography for In Vivo Imaging of Glioblastoma Xenografts

Published on: April 26, 2018

Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs
10:32

Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs

Published on: December 19, 2019

Related Experiment Videos

Last Updated: Sep 26, 2026

Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models
10:04

Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models

Published on: March 13, 2018

Fluorescence Molecular Tomography for In Vivo Imaging of Glioblastoma Xenografts
07:52

Fluorescence Molecular Tomography for In Vivo Imaging of Glioblastoma Xenografts

Published on: April 26, 2018

Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs
10:32

Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs

Published on: December 19, 2019

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Articles linked to this work by shared authors, journal, and citation graph.

Increased tumor glycolysis is associated with decreased immune infiltration across human solid tumors.

Frontiers in immunology·2022

Lactate Dehydrogenase A Depletion Alters MyC-CaP Tumor Metabolism, Microenvironment, and CAR T Cell Therapy.

Molecular therapy oncolytics·2020

18F-Fluorocholine PET uptake correlates with pathologic evidence of recurrent tumor after stereotactic radiosurgery for brain metastases.

European journal of nuclear medicine and molecular imaging·2019

Molecular Imaging with Reporter Genes: Has Its Promise Been Delivered?

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2019

Inhibition of prostate cancer proliferation by Deferiprone.

NMR in biomedicine·2017

Tumor stroma interaction is mediated by monocarboxylate metabolism.

Experimental cell research·2017

Spatial omics resolves adrenergic and mesenchymal cell states in neuroblastoma.

Cancer cell·2026

Chromatin plasticity and lineage repurposing: When gastric identity turns acidic.

Cancer cell·2026

Chromatin accessibility trajectories reveal pre-cancerous epigenetic priming and an acid-driven immunotherapy-resistant gastric cancer subtype.

Cancer cell·2026

Chemotherapy enhances cancer vaccine efficacy and expands stem-like TCF1+CD8+ T cells.

Cancer cell·2026

Beyond BMI: The diet-microbiome context of the obesity paradox.

Cancer cell·2026

The wu wei of brain metastases: When the gift of a pause is also a vulnerability.

Cancer cell·2026

Targeting KIT and PDGFRA mutations in advanced gist: current and future clinical implications.

Expert review of anticancer therapy·2026

Biomaterial-Based Controlled Release Systems for Spinal Cord Remyelination.

Advanced materials (Deerfield Beach, Fla.)·2026

Molecular mechanism of Xanthotoxol against gastric cancer: A comprehensive study integrating network pharmacology, computer simulations, and experimental validation.

Animal models and experimental medicine·2026

ZNF865 (BLST) a Novel Regulator of DNA Damage and Cell Senescence in Back Pain.

Aging cell·2026

Contributions of the anion exchangers SLC26A1, SLC26A2, SLC26A3, and SLC26A6 to intestinal oxalate transport in human Caco2-BBE cells.

Physiological reports·2026

[Chinese expert consensus on the management of corneal and ocular surface adverse events related to antibody-drug conjugates (2026)].

[Zhonghua yan ke za zhi] Chinese journal of ophthalmology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us